Nouvelle déclaration d'incident
No de la demande: 2021-2658
Numéro de référence du titulaire d'homologation: 2020-CA-000195
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 400 Plaza Drive
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094-3688
Incident chez un animal domestique
Pays: CANADA
État: QUEBEC
ARLA No d'homologation 25620 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Hartz UltraGuard Flea and Tick Collar for Dogs
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Dog / Chien
Boston Terrier
1
Femme
4
7.26
kg
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
Système
Unknown / Inconnu
Non
Non
Unknown/Inconnu
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 13-Jun-2020, a 4 year old, 7.26 kilogram, neutered, female, Boston Terrier dog, in unknown condition, with no known concomitant medical conditions, was administered 1 collar of Hartz UltraGuard Flea and Tick Collar for Dogs (Tetrachlorvinphos) via the topical route by the animal owner. on 15-Jun-2020, the dog developed diarrhea, lethargy and vomited once. The collar was removed by the animal owner and the dog was fed a bland diet of ground turkey and rice. On 19-Jun-2020, the dog's skin felt warm to the touch. On an unspecified date, the pet owner spoke with a veterinarian and a fecal exam was recommended. The clinical signs continued. Veterinary evaluation was recommended for persistent clinical signs. No further information was received in this case.
Modérée
Assessment: If the collar were licked by the dog or if a small amount of the collar was ingested, minor GI irritation resulting in vomiting, diarrhea, and inappetance may occur. The persistent signs described are not expected, especially in the absence of ingestion of the product. Other causes including dietary indiscretion, intestinal parasites, and viral infection should also be considered. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.